Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Baxter
Colorcon
Harvard Business School

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Raltitrexed


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Raltitrexed?

Raltitrexed is an investigational drug.

There have been 47 clinical trials for Raltitrexed. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2013.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Carcinoma, and Neoplasm Metastasis. The leading clinical trial sponsors are Fudan University, National Cancer Institute (NCI), and Jiangsu Cancer Institute & Hospital.

There are eight hundred and ninety-seven US patents protecting this investigational drug and fourteen international patents.

Recent Clinical Trials for Raltitrexed
TitleSponsorPhase
SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal CancerSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2
Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCCFirst Affiliated Hospital of Wenzhou Medical UniversityEarly Phase 1
Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCCFirst Affiliated Hospital of Zhejiang UniversityEarly Phase 1

See all Raltitrexed clinical trials

Clinical Trial Summary for Raltitrexed

Top disease conditions for Raltitrexed
Top clinical trial sponsors for Raltitrexed

See all Raltitrexed clinical trials

US Patents for Raltitrexed

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Raltitrexed ⤷  Sign up for a Free Trial Heat shock protein 70 (hsp-70) receptor ligands Duke University (Durham, NC) ⤷  Sign up for a Free Trial
Raltitrexed ⤷  Sign up for a Free Trial Compounds and their methods of use Agios Pharmaceuticals, Inc. (Cambridge, MA) ⤷  Sign up for a Free Trial
Raltitrexed ⤷  Sign up for a Free Trial Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA) ⤷  Sign up for a Free Trial
Raltitrexed ⤷  Sign up for a Free Trial Method of diagnosing and treating cancer using B-catenin splice variants The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) ⤷  Sign up for a Free Trial
Raltitrexed ⤷  Sign up for a Free Trial Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ⤷  Sign up for a Free Trial
Raltitrexed ⤷  Sign up for a Free Trial Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ⤷  Sign up for a Free Trial
Raltitrexed ⤷  Sign up for a Free Trial Use of inhibitors of Bruton's tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Raltitrexed

Drugname Country Document Number Estimated Expiration Related US Patent
Raltitrexed World Intellectual Property Organization (WIPO) WO2015148714 2034-03-25 ⤷  Sign up for a Free Trial
Raltitrexed Australia AU2015231053 2034-03-21 ⤷  Sign up for a Free Trial
Raltitrexed Brazil BR112016021620 2034-03-21 ⤷  Sign up for a Free Trial
Raltitrexed Canada CA2943339 2034-03-21 ⤷  Sign up for a Free Trial
Raltitrexed China CN106231900 2034-03-21 ⤷  Sign up for a Free Trial
Raltitrexed Eurasian Patent Organization EA201691896 2034-03-21 ⤷  Sign up for a Free Trial
Raltitrexed European Patent Office EP3119199 2034-03-21 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Baxter
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.